Literature DB >> 32450175

Circular RNAs in the pathogenesis of atherosclerosis.

Qidong Cao1, Ziyuan Guo1, Shuangshuang Du1, Hao Ling1, Chunli Song2.   

Abstract

Atherosclerosis is a common cause of cardiovascular and cerebrovascular diseases. Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), and circular RNAs (circRNAs) have attracted substantial attention for their roles in various physiological and pathological processes. In recent years, research on the roles of circRNAs in atherosclerosis has progressed rapidly, and they have been implicated in the pathophysiological processes underlying the development of atherosclerosis, including changes in the functions of endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and macrophages. In this review article, we summarize currently available data regarding the role of circRNAs in atherosclerosis and how circRNAs influence the development of atherosclerosis by regulating ECs, VSMCs, and macrophages. We also discuss their potential as diagnostic biomarkers for coronary artery disease.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular disease; Circular RNAs; Coronary artery disease

Year:  2020        PMID: 32450175     DOI: 10.1016/j.lfs.2020.117837

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  18 in total

Review 1.  The Role of Extracellular Non-coding RNAs in Atherosclerosis.

Authors:  Yuting Cui; Yating Zhou; Ni Gan; Qiong Xiang; Mengdie Xia; Wei Liao; Xi-Long Zheng; Juan Peng; Zhihan Tang
Journal:  J Cardiovasc Transl Res       Date:  2022-03-01       Impact factor: 3.216

Review 2.  MicroRNAs and Circular RNAs in Lipoprotein Metabolism.

Authors:  Pablo Fernández-Tussy; Inmaculada Ruz-Maldonado; Carlos Fernández-Hernando
Journal:  Curr Atheroscler Rep       Date:  2021-05-10       Impact factor: 5.967

3.  circ_0003204 Regulates Cell Growth, Oxidative Stress, and Inflammation in ox-LDL-Induced Vascular Endothelial Cells via Regulating miR-942-5p/HDAC9 Axis.

Authors:  Huan Wan; Ting You; Wei Luo
Journal:  Front Cardiovasc Med       Date:  2021-04-01

Review 4.  Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms.

Authors:  Raziyeh Salami; Marziyeh Salami; Alireza Mafi; Omid Vakili; Zatollah Asemi
Journal:  Cell Commun Signal       Date:  2022-01-28       Impact factor: 5.712

Review 5.  Epigenetic Regulation in Pathology of Atherosclerosis: A Novel Perspective.

Authors:  Haishuang Tang; Zhangwei Zeng; Chenghao Shang; Qiang Li; Jianmin Liu
Journal:  Front Genet       Date:  2021-12-15       Impact factor: 4.599

Review 6.  Non-coding RNA-associated competitive endogenous RNA regulatory networks: Novel diagnostic and therapeutic opportunities for hepatocellular carcinoma.

Authors:  Sattar Khashkhashi Moghadam; Babak Bakhshinejad; Ali Khalafizadeh; Bashdar Mahmud Hussen; Sadegh Babashah
Journal:  J Cell Mol Med       Date:  2021-12-14       Impact factor: 5.310

7.  A circular RNA, circUSP36, accelerates endothelial cell dysfunction in atherosclerosis by adsorbing miR-637 to enhance WNT4 expression.

Authors:  Jian-Guo Huang; Xia Tang; Jiang-Jie Wang; Jia Liu; Ping Chen; Yan Sun
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 8.  Roles of circular RNAs in colorectal cancer.

Authors:  Mingying Zhang; Shubin Wang
Journal:  Oncol Lett       Date:  2021-06-10       Impact factor: 2.967

9.  hsa_circWDR37_016 Regulates Hypoxia-Induced Proliferation of Pulmonary Arterial Smooth Muscle Cells.

Authors:  Shan-Shan Li; Shuang Liang; Yao Long; Xu Chen; Xin Jin
Journal:  Cardiovasc Ther       Date:  2022-01-17       Impact factor: 3.023

10.  FABP4 activates the JAK2/STAT2 pathway via Rap1a in the homocysteine-induced macrophage inflammatory response in ApoE-/- mice atherosclerosis.

Authors:  Lingbo Xu; Huiping Zhang; Yanhua Wang; Anning Yang; Xiaoyan Dong; Lingyu Gu; Dayue Liu; Ning Ding; Yideng Jiang
Journal:  Lab Invest       Date:  2021-11-01       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.